319 related articles for article (PubMed ID: 20945274)
1. Sleeping sickness pathogen (Trypanosoma brucei) and natural products: therapeutic targets and screening systems.
Hannaert V
Planta Med; 2011 Apr; 77(6):586-97. PubMed ID: 20945274
[TBL] [Abstract][Full Text] [Related]
2. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei.
Mackey ZB; Baca AM; Mallari JP; Apsel B; Shelat A; Hansell EJ; Chiang PK; Wolff B; Guy KR; Williams J; McKerrow JH
Chem Biol Drug Des; 2006 May; 67(5):355-63. PubMed ID: 16784460
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis.
Wang CC
Annu Rev Pharmacol Toxicol; 1995; 35():93-127. PubMed ID: 7598514
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
[TBL] [Abstract][Full Text] [Related]
5. [An efficacy trial on Trypanosoma brucei brucei of molecules permeating the blood-brain barrier and of megazol].
Marie-Daragon A; Rouillard MC; Bouteille B; Bisser S; de Albuquerque C; Chauvière G; Périé J; Dumas M
Bull Soc Pathol Exot; 1994; 87(5):347-52. PubMed ID: 7496199
[TBL] [Abstract][Full Text] [Related]
6. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
[TBL] [Abstract][Full Text] [Related]
7. Current chemotherapy of human African trypanosomiasis.
Docampo R; Moreno SN
Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
[TBL] [Abstract][Full Text] [Related]
8. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
9. Trypanocidal drugs: mechanisms, resistance and new targets.
Wilkinson SR; Kelly JM
Expert Rev Mol Med; 2009 Oct; 11():e31. PubMed ID: 19863838
[TBL] [Abstract][Full Text] [Related]
10. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
[TBL] [Abstract][Full Text] [Related]
11. Drugs and drug resistance in African trypanosomiasis.
Delespaux V; de Koning HP
Drug Resist Updat; 2007; 10(1-2):30-50. PubMed ID: 17409013
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
Hiltensperger G; Jones NG; Niedermeier S; Stich A; Kaiser M; Jung J; Puhl S; Damme A; Braunschweig H; Meinel L; Engstler M; Holzgrabe U
J Med Chem; 2012 Mar; 55(6):2538-48. PubMed ID: 22376072
[TBL] [Abstract][Full Text] [Related]
13. Newly identified antibacterial compounds are topoisomerase poisons in African trypanosomes.
Tang SC; Shapiro TA
Antimicrob Agents Chemother; 2010 Feb; 54(2):620-6. PubMed ID: 20008775
[TBL] [Abstract][Full Text] [Related]
14. Whole-organism high-throughput screening against Trypanosoma brucei brucei.
Jones AJ; Avery VM
Expert Opin Drug Discov; 2013 May; 8(5):495-507. PubMed ID: 23540598
[TBL] [Abstract][Full Text] [Related]
15. Diamidine activity against trypanosomes: the state of the art.
Soeiro MN; de Castro SL; de Souza EM; Batista DG; Silva CF; Boykin DW
Curr Mol Pharmacol; 2008 Jun; 1(2):151-61. PubMed ID: 20021429
[TBL] [Abstract][Full Text] [Related]
16. Anti-trypanosomal activities of DNA topoisomerase inhibitors.
Deterding A; Dungey FA; Thompson KA; Steverding D
Acta Trop; 2005 Mar; 93(3):311-6. PubMed ID: 15715983
[TBL] [Abstract][Full Text] [Related]
17. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
[TBL] [Abstract][Full Text] [Related]
18. Kola acuminata proanthocyanidins: a class of anti-trypanosomal compounds effective against Trypanosoma brucei.
Kubata BK; Nagamune K; Murakami N; Merkel P; Kabututu Z; Martin SK; Kalulu TM; Huq M; Yoshida M; Ohnishi-Kameyama M; Kinoshita T; Duszenko M; Urade Y
Int J Parasitol; 2005 Jan; 35(1):91-103. PubMed ID: 15619520
[TBL] [Abstract][Full Text] [Related]
19. In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
Merschjohann K; Steverding D
Exp Parasitol; 2008 Apr; 118(4):637-40. PubMed ID: 18226810
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma brucei infection in a HIV positive Ugandan male.
Dill EA; Renault C; Kirkpatrick BD
Clin Lab Sci; 2011; 24(2):85-8. PubMed ID: 21657140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
